Streetbeat News

Price Targets

AMZN

Scotiabank has initiated coverage on Amazon.com with a Sector Outperform rating and set a price target of $245.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:28 pm

CDLX

Evercore ISI Group has initiated coverage on Cardlytics (NASDAQ:CDLX) with an In-Line rating and set a price target of $4.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:27 pm

META

Scotiabank has initiated coverage on Meta Platforms with a Sector Perform rating and set a price target of $585.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:26 pm

CCG

Maxim Group has initiated coverage on Cheche Group (NASDAQ:CCG) with a Buy rating and set a price target of $2.5.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:22 pm

RACE

JP Morgan analyst Ryan Brinkman has upgraded Ferrari (NYSE:RACE) from Neutral to Overweight and increased the price target from $385 to $525.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:12 pm

SQM

JP Morgan has downgraded Sociedad Quimica Y Minera (SQM) from Overweight to Neutral and reduced its price target from $55 to $44.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:09 pm

NRIX

Jefferies has initiated coverage on Nurix Therapeutics with a Buy rating and set a price target of $41.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:02 pm

ANIP

ANI Pharmaceuticals (NASDAQ:ANIP) has been analyzed by 5 analysts, showing a range of perspectives from bullish to bearish. The average 12-month price target has decreased by 8.54% to $79.8. Analysts have adjusted their ratings and price targets, reflecting their views on the company's market standing. ANI Pharmaceuticals has shown positive revenue growth and strong financial health indicators.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 12:01 pm

VALN

Valneva (NASDAQ:VALN) has received mixed analyst ratings over the past three months, with a majority being bullish. The average 12-month price target is $24.5, down 3.92% from the previous average. Analyst Edward White from HC Wainwright & Co. has adjusted his price targets downward while maintaining a 'Buy' rating. Valneva faces challenges with revenue decline and high debt but shows strong net margins.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 12:01 pm

AX

Analysts have shared mixed views on Axos Financial (NYSE:AX) over the past three months, with a recent positive shift in price targets. The average 12-month price target has increased by 13.23% to $80.17. Analysts have adjusted their ratings and price targets, reflecting their response to Axos Financial's performance and market conditions. The company has shown strong financial performance with a 23.24% revenue growth rate, a net margin of 36.53%, and a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 12:01 pm